Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President of Int'l Operations

President and CEO

Chief Operating Officer

Chief Financial Officer & SVP

Chief Marketing Officer & SVP

Chief Operating Officer & SVP

Chief Financial Officer

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals. It operates through United States, internationally, and Operating Cost segments. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, clinics, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. Alimera Sciences, Inc. was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-26	Premium	sold (taxes)	Premium	Premium	Premium	President of Int'l Operations
2024-01-10	Premium	sold (taxes)	Premium	Premium	Premium	President of Int'l Operations
2023-10-02	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-10-02	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-09-14	Premium	bought	Premium	Premium	Premium	-
2023-09-14	Premium	sold	Premium	Premium	Premium	-
2023-08-15	Premium	acquired	Premium	Premium	Premium	-
2023-08-15	Premium	acquired	Premium	Premium	Premium	-
2023-08-15	Premium	acquired	Premium	Premium	Premium	-
2023-08-15	Premium	acquired	Premium	Premium	Premium	-
2023-05-17	Premium	bought	Premium	Premium	Premium	-
2023-03-26	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-03-26	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer & SVP
2023-03-26	Premium	acquired	Premium	Premium	Premium	Chief Marketing Officer & SVP
2023-03-26	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer & SVP
2023-03-24	Premium	sold	Premium	Premium	Premium	-
2023-02-03	Premium	sold (taxes)	Premium	Premium	Premium	Chief Operating Officer & SVP
2023-01-09	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer & SVP
2022-10-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-10-31	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-10-31	Premium	acquired	Premium	Premium	Premium	Chief Marketing Officer & SVP
2022-04-29	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-04-29	Premium	acquired	Premium	Premium	Premium	Chief Marketing Officer & SVP
2022-04-29	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-02-08	Premium	sold	Premium	Premium	Premium	-

ALIM - Alimera Sciences Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ALIM